ArticlePharmacological research2025

Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice.

Syed Tareq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.